Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hedge Replication ETF (HDG)

Hedge Replication ETF (HDG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Proshare Advisors LLC
  • Assets Under Management 24,367,200
  • Shares Outstanding, K 470
  • 60-Month Beta 0.33
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 1.45 (2.79%)
  • Most Recent Dividend 0.356 on 09/24/25
  • Management Fee 0.95%
  • INDUSTRY GROUPING:

    ETFs - Managed ETFs

Options Overview Details

View History
  • Implied Volatility 34.25% (+34.25%)
  • Historical Volatility 5.53%
  • IV Percentile 89%
  • IV Rank 100.00%
  • IV High 34.25% on 12/02/25
  • IV Low 28.82% on 10/23/25
  • Expected Move (DTE 12) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 17
  • Open Int (30-Day) 36
  • Expected Range 51.85 to 51.85

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.72 +2.22%
on 11/21/25
52.05 -0.39%
on 12/05/25
+0.22 (+0.43%)
since 11/05/25
3-Month
49.91 +3.88%
on 09/08/25
52.05 -0.39%
on 12/05/25
+1.06 (+2.08%)
since 09/05/25
52-Week
46.28 +12.02%
on 04/07/25
52.05 -0.39%
on 12/05/25
+1.45 (+2.87%)
since 12/05/24

Most Recent Stories

More News
Candel’s Final Survival Data From Lung Cancer Drug Trial Lifts Stock After-Hours, Fuels Retail Optimism

The study included 46 fully treated patients, with 37% of those with progressive disease still alive after two years.

CADL : 5.33 (+1.33%)
VTI : 337.56 (+0.14%)
HDG : 51.85 (+0.25%)
IWM : 250.77 (-0.42%)
Candel Therapeutics Stock Rallies On Canaccord’s Vote Of Confidence In Lead Cancer Drug: Retail Traders Rejoice

CAN-2409 could become a “best-in-class therapy” for borderline resectable pancreatic ductal adenocarcinoma, according to the analyst.

CADL : 5.33 (+1.33%)
VTI : 337.56 (+0.14%)
HDG : 51.85 (+0.25%)
IWM : 250.77 (-0.42%)
Mullen's Stock Plumbs New Depths After Q1 Net Loss Balloons By 46%, Retail Traders Throw In The Towel

Most losses were non-cash expenses totaling $91 million, making up 79% of the quarter's total loss.

IWC : 160.26 (-0.58%)
VTI : 337.56 (+0.14%)
HDG : 51.85 (+0.25%)
MULN : 0.0660 (+3.13%)
Mullen Automotive Stock In Reverse Gear On 1-For-60 Reverse Split Plan: Retail Sentiment Mixed

The stock has lost over 99% of its value in the past year, with the upcoming earnings report on Feb. 17 seen as a key test for the company’s growth narrative.

IWC : 160.26 (-0.58%)
VTI : 337.56 (+0.14%)
HDG : 51.85 (+0.25%)
MULN : 0.0660 (+3.13%)
Candel Therapeutics Stock Headed For 20% Weekly Gains: Retail Over The Moon With BofA's 'Buy' Call

The analyst noted that CAN-2409's early data in prostate cancer suggests the potential for a meaningful breakthrough, given the lack of significant advancements in available treatments.

CADL : 5.33 (+1.33%)
VTI : 337.56 (+0.14%)
HDG : 51.85 (+0.25%)
IWM : 250.77 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

ProShares Hedge Replication ETF seeks investment results, before fees and expenses, that track the performance of the Merrill Lynch Factor Model - Exchange Series.

See More

Top 10 Holdings

Name % Holdings
Hedge Replication ETF 0.00%
S&P 500 Index SWAP Societe Generale 0.00%
EURO E-MINI FUT CURRENCY 15/DEC/2025 EEZ5 CURNCY 0.00%
MSCI Emerging Markets Index (EEM) SWAP UBS AG 0.00%
MSCI EAFE Index (EFA) SWAP UBS AG 0.00%
MSCI Emerging Markets Index (EEM) SWAP Societe Generale 0.00%
MSCI EAFE Index (EFA) SWAP Societe Generale 0.00%
Russell 2000 Index SWAP Societe Generale 0.00%
Russell 2000 Index SWAP UBS AG 0.00%
UNITED STATES OF AMERICA BILL ZERO CPN 05/MAR/2026 USD 100 0.00%

See More

Key Turning Points

3rd Resistance Point 52.19
2nd Resistance Point 52.12
1st Resistance Point 51.98
Last Price 51.85
1st Support Level 51.78
2nd Support Level 51.71
3rd Support Level 51.57

See More

52-Week High 52.05
Last Price 51.85
Fibonacci 61.8% 49.85
Fibonacci 50% 49.17
Fibonacci 38.2% 48.48
52-Week Low 46.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar